Retour sur lavenir.net
   AZELIS GROUP 11.710 € (+0,43 %)     AB INBEV 71.960 € (+1,81 %)     ARGENX SE 807.200 € (+0,35 %)     ROULARTA 12.000 € (+4,80 %)     VASTNED 27.200 € (0,00 %)     VAN DE VELDE 29.200 € (-0,34 %)     TESSENDERLO 17.160 € (+0,59 %)     AGEAS 75.500 € (-0,26 %)     CIE BOIS SAUVAGE 267.000 € (+0,38 %)     KBC 114.100 € (-1,60 %)     ECONOCOM GROUP 1.490 € (+2,76 %)     KBC ANCORA 92.600 € (-1,91 %)     SOFINA 275.000 € (+0,73 %)     KINEPOLIS GROUP 48.100 € (-0,31 %)     SOLVAY 23.820 € (0,00 %)     UCB 281.400 € (+0,50 %)     ACCENTIS 0.027 € (+1,92 %)     RECTICEL 12.060 € (-2,90 %)     ACKERMANS V.HAAREN 263.200 € (-0,38 %)     WERELDHAVE BELGIUM 50.200 € (-1,57 %)     CMB.TECH 16.420 € (-2,15 %)     LOTUS BAKERIES 13 580.000 € (+1,34 %)     FLUXYS BELGIUM D 21.000 € (0,00 %)     JENSEN-GROUP 72.200 € (-2,43 %)     ONTEX GROUP 1.400 € (0,00 %)     DECEUNINCK 2.400 € (-0,83 %)     TINC 10.320 € (-0,58 %)     CENERGY 22.220 € (-1,24 %)     INCLUSIO SA/NV 15.100 € (-0,66 %)     BANQUP GROUP 0.880 € (+2,33 %)     SYENSQO 76.450 € (-1,16 %)     SHURGARD 24.700 € (+3,13 %)     WDP 19.050 € (-0,21 %)     CAMPINE 179.500 € (+2,57 %)     ENERGYVISION 17.600 € (-1,57 %)     MONTEA 65.600 € (+1,23 %)     XIOR 24.700 € (+0,61 %)     DEME GROUP 167.400 € (-0,48 %)     IBA 16.000 € (-2,79 %)     GBL 77.750 € (+0,45 %)     ORANGE BELGIUM 22.200 € (-0,45 %)     SOLVAC 82.500 € (-1,79 %)     GIMV 49.450 € (+0,30 %)     AEDIFICA 63.650 € (+0,55 %)     HOME INVEST BE. 17.680 € (-0,23 %)     TUBIZE-FIN 229.800 € (+0,97 %)     BREDERODE 100.600 € (-1,18 %)     TITAN S.A. 47.100 € (-1,17 %)     BIOTALYS 1.616 € (-0,25 %)     ELIA GROUP 128.900 € (-0,31 %)     BPOST 1.068 € (+0,56 %)     FAGRON 23.450 € (+0,21 %)     D'IETEREN GROUP 172.900 € (+0,93 %)     AGFA-GEVAERT 0.405 € (-0,74 %)     COLRUYT 34.540 € (-0,35 %)     BEKAERT 40.250 € (-0,25 %)     NEXTENSA 45.705 € (-0,95 %)     BARCO 6.400 € (-1,31 %)     NYXOAH 0.790 € (-4,70 %)     RETAIL ESTATES 61.800 € (-0,64 %)  
   ESSILORLUXOTTICA 184.300 € (+3,42 %)     SCHNEIDER ELECTRIC 237.500 € (-4,08 %)     ASM INTERNATIONAL 729.800 € (-7,57 %)     SANOFI 79.740 € (+4,71 %)     WOLTERS KLUWER 87.000 € (+2,72 %)     HEINEKEN 79.560 € (+2,21 %)     ALTAREA 73.700 € (-0,81 %)     EXOR NV 71.200 € (-0,35 %)     L'OREAL 436.950 € (+2,93 %)     ADYEN 826.900 € (+1,35 %)     CALIBRE 0.000 € (-25,00 %)     CARREFOUR 13.045 € (-0,27 %)     SHELL PLC 48.680 € (+0,56 %)     BE SEMICONDUCTOR 154.000 € (-5,72 %)     ACHETER-LOUER.FR 0.000 € (0,00 %)     ASML HOLDING 1 412.800 € (-6,11 %)     NOS, SGPS 5.210 € (+2,36 %)     THALES 235.700 € (-1,13 %)     AIR LIQUIDE 180.900 € (+1,98 %)     TOTALENERGIES 85.430 € (+0,98 %)     STELLANTIS NV 4.142 € (-1,94 %)     SOCIETE GENERALE 60.990 € (-2,28 %)     BIOPHYTIS 0.031 € (-7,78 %)     DANONE 65.520 € (+1,77 %)     ABIVAX 79.050 € (-2,53 %)     DASSAULT AVIATION 307.000 € (-0,26 %)     BASIC-FIT 29.460 € (-0,47 %)     ALFEN 10.240 € (-1,35 %)     PROSUS 34.290 € (-0,04 %)     UNIBAIL-RODAMCO-WE 91.040 € (-0,61 %)     HERMES INTL 1 293.500 € (+2,17 %)     ENGIE 23.430 € (-0,72 %)     ORANGE 14.470 € (+0,21 %)     BOUYGUES 40.800 € (-0,95 %)     RENAULT 27.650 € (-1,85 %)     BNP PARIBAS ACT.A 85.650 € (-2,28 %)     LEGRAND 131.000 € (-2,67 %)     ARCELORMITTAL SA 53.600 € (-2,15 %)     KERING 177.460 € (+0,67 %)     WERELDHAVE 17.260 € (+1,29 %)     EUROFINS SCIENT. 87.720 € (+0,73 %)     SIGNIFY NV 15.260 € (-0,52 %)     AEGON 7.394 € (-1,04 %)     AKZO NOBEL 59.300 € (+0,75 %)     STMICROELECTRONICS 41.880 € (-5,26 %)     UNILEVER 58.600 € (+2,36 %)     RANDSTAD NV 40.960 € (+1,76 %)     BUREAU VERITAS 29.300 € (+0,76 %)     MAUREL ET PROM 8.140 € (+0,43 %)     CVC CAPITAL 13.420 € (+1,67 %)     GTT 185.700 € (-2,88 %)     CEGEDIM 9.700 € (-0,21 %)     POSTNL 0.802 € (-0,50 %)     CREDIT AGRICOLE 14.990 € (-1,99 %)     EURONEXT 177.600 € (+0,40 %)     ARCADIS 45.300 € (+0,35 %)     AHOLD DEL 32.750 € (+0,71 %)     LVMH 387.000 € (+0,82 %)     ING GROEP N.V. 28.255 € (-2,06 %)     ABN AMRO BANK N.V. 39.620 € (-1,34 %)  
News Réglementées
03/01/2023 09:30

Empower Clinics Subsidiary Signs Laboratory Services Agreement with US Healthcare Provider for Underserved Americans

MediSure Laboratory will provide clinical laboratory services to Specialist Network of North America as part of recently announced partnership

VANCOUVER, BC / ACCESSWIRE / January 3, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - today announced that Medisure Laboratory ("Medisure labs") signed a clinical laboratory services agreement with Specialist Network of North America Inc. (SSNA).

The agreement follows the partnership announced on December 7th between Empower and SNNA to launch a healthcare network whose mission is to bring access to quality and affordable specialist healthcare to underserved communities across the US.

The Laboratory Services Agreement will provide SNNA the opportunity to offer its patients a full range of required cardiology screening panels and point-of-care testing products that are integral to diagnosis and the provision of treatment options. Medisure Labs generates new consistent monthly revenue and plays an important role in helping underserved patients.

"This agreement is exactly the type of accretive benefit that I envisioned when Empower partnered with SSNA last month", stated Steven McAuley, Chairman and CEO of Empower Clinics "With Medisure Labs, we have a laboratory that has state-of-the art technology and a pristine operating environment. We continue to aggressively pursue and replicate laboratory service agreements like the one with SSNA to maximize our return on investment in Medisure Laboratory."

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT SPECIALIST NETWORK OF NORTH AMERICA

https://specnethealth.com/

We are a healthcare network whose mission is to bring access to quality and affordable specialist healthcare to underserved communities across the US. We aim to facilitate the effective and timely delivery of that care by creating and deploying a collaborative network of strategic partnerships including clinics, telemedicine and insurance providers.

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Media:

Steven McAuley
CEO
s.mcauley@empowerclinics.com
+1 855-855-9058

Investors:

Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: the likelihood or ability for the Company to secure new testing business from SNNA. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE: Empower Clinics Inc.



View source version on accesswire.com:
https://www.accesswire.com/733754/Empower-Clinics-Subsidiary-Signs-Laboratory-Services-Agreement-with-US-Healthcare-Provider-for-Underserved-Americans

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière